MiR-126 negatively regulates PLK-4 to impact the development of hepatocellular carcinoma via ATR/CHEK1 pathway
MiR-126 negatively regulates PLK-4 to impact the development of hepatocellular carcinoma via ATR/CHEK1 pathwayMiR-126 negatively regulates PLK-4 to impact the development of hepatocellular carcinoma via ATR/CHEK1 pathway, Published online: 12 October 2018; doi:10.1038/s41419-018-1020-0MiR-126 negatively regulates PLK-4 to impact the development of hepatocellular carcinoma via ATR/CHEK1 pathway
Source: Cell death and disease - Category: Internal Medicine Authors: Jie Bao Yan Yu Jianan Chen Yuting He Xiaolong Chen Zhigang Ren Chen Xue Liwen Liu Qiuyue Hu Juan Li Guangying Cui Ranran Sun Source Type: research
More News: Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Internal Medicine | Liver Cancer